324 related articles for article (PubMed ID: 23846791)
1. More than a simple storage organ: adipose tissue as a source of adipokines involved in cardiovascular disease.
Rega-Kaun G; Kaun C; Wojta J
Thromb Haemost; 2013 Oct; 110(4):641-50. PubMed ID: 23846791
[TBL] [Abstract][Full Text] [Related]
2. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.
Fuster JJ; Ouchi N; Gokce N; Walsh K
Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642
[TBL] [Abstract][Full Text] [Related]
3. Adipokines in inflammation, insulin resistance and cardiovascular disease.
Li ZY; Wang P; Miao CY
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):888-96. PubMed ID: 21910745
[TBL] [Abstract][Full Text] [Related]
4. [Fat mass expansion, fatty acids and adipokines: metabolic markers and risk factors for cardiovascular pathologies].
Lafontan M
Ann Pharm Fr; 2013 Jan; 71(1):13-26. PubMed ID: 23348852
[TBL] [Abstract][Full Text] [Related]
5. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
Kravchun P; Kadykova O; Gabisoniia T
Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
[TBL] [Abstract][Full Text] [Related]
6. Adipocytokines in relation to cardiovascular disease.
Van de Voorde J; Pauwels B; Boydens C; Decaluwé K
Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981
[TBL] [Abstract][Full Text] [Related]
7. The adipose tissue as an endocrine organ.
Adamczak M; Wiecek A
Semin Nephrol; 2013 Jan; 33(1):2-13. PubMed ID: 23374889
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cardiovascular function by adipokines.
DeClercq V; Enns JE; Yeganeh A; Taylor CG; Zahradka P
Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):59-72. PubMed ID: 22882074
[TBL] [Abstract][Full Text] [Related]
9. Adipokines at the crossroad between obesity and cardiovascular disease.
Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
11. Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease.
Meijer RI; Serne EH; Smulders YM; van Hinsbergh VW; Yudkin JS; Eringa EC
Curr Diab Rep; 2011 Jun; 11(3):211-7. PubMed ID: 21461998
[TBL] [Abstract][Full Text] [Related]
12. Role of adipokines in obesity-associated hypertension.
Vlasova M; Purhonen AK; Jarvelin MR; Rodilla E; Pascual J; Herzig KH
Acta Physiol (Oxf); 2010 Oct; 200(2):107-27. PubMed ID: 20653609
[TBL] [Abstract][Full Text] [Related]
13. Adipokines and thrombosis.
Schäfer K; Konstantinides S
Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):864-71. PubMed ID: 21848866
[TBL] [Abstract][Full Text] [Related]
14. Emerging functions of adipokines in linking the development of obesity and cardiovascular diseases.
Su X; Peng D
Mol Biol Rep; 2020 Oct; 47(10):7991-8006. PubMed ID: 32888125
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
Goralski KB; Sinal CJ
Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
[TBL] [Abstract][Full Text] [Related]
16. Role of adipokines in cardiovascular disease.
Mattu HS; Randeva HS
J Endocrinol; 2013 Jan; 216(1):T17-36. PubMed ID: 23160967
[TBL] [Abstract][Full Text] [Related]
17. Obesity associated disease risk: the role of inherent differences and location of adipose depots.
Hill JH; Solt C; Foster MT
Horm Mol Biol Clin Investig; 2018 Mar; 33(2):. PubMed ID: 29547393
[TBL] [Abstract][Full Text] [Related]
18. Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue.
Lappas M
Metabolism; 2014 Feb; 63(2):250-62. PubMed ID: 24262292
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.
Murdolo G; Piroddi M; Luchetti F; Tortoioli C; Canonico B; Zerbinati C; Galli F; Iuliano L
Biochimie; 2013 Mar; 95(3):585-94. PubMed ID: 23274128
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanisms of obesity paradox.
Antonopoulos AS; Tousoulis D
Cardiovasc Res; 2017 Jul; 113(9):1074-1086. PubMed ID: 28549096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
